Arjo AB (publ) ARJO-B.ST
Nasdaq Stockholm · Healthcare · Medical Distribution
36.68 SEK
−0.2%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Arjo
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 9,979 | 10,980 | 11,292 | 11,000 |
| EBITDA | 1,699 | 1,961 | 2,013 | 1,769 |
| Net income | 449 | 480 | 498 | 334 |
| Balance sheet | ||||
| Equity | 7,432 | 7,582 | 8,338 | 7,457 |
| Total debt | 6,313 | 5,486 | 5,418 | 5,353 |
| Cash | 949 | 923 | 892 | 836 |
| Net debt | 5,364 | 4,563 | 4,526 | 4,517 |
| Ratios and per share | ||||
| EBITDA margin | 17.0% | 17.9% | 17.8% | 16.1% |
| Profit margin | 4.5% | 4.4% | 4.4% | 3.0% |
| Return on equity | 6.0% | 6.3% | 6.0% | 4.5% |
| Earnings/share (SEK) | 1.65 | 1.76 | 1.83 | 1.23 |
| Book value/share (SEK) | 27.29 | 27.84 | 30.61 | 27.38 |
| Shares outstanding (M) | 272 | 272 | 272 | 272 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 29.9 |
| P/B | 1.3 |
| EV / EBITDA | 8.2 |
| Net debt / EBITDA | 2.6 |
| Return on equity | 4.5% |
| Profit margin | 3.0% |
| Beta 1Y | 0.45 |
| Revenue growth 1Y | −2.6% |
| Revenue CAGR 3Y | +3.3% |
| Earnings/share CAGR 3Y | −9.4% |
| ROE avg. 3Y | 5.6% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 0.95 |
| 2025 | 0.95 |
| 2024 | 0.90 |
| 2023 | 0.85 |
| 2022 | 1.15 |
Not investment advice. Figures may contain errors from the data source.